Articles & Resources

Market Trends

Below is a collection of articles, resources and stories from the Invetech team and industry experts, sharing their knowledge, experiences and advice on product development and market trends.

Market Trends

Clear filter

The Drive to More Near-Patient Testing Post-COVID

In this episode of Spilling the Tea, we talk with David Satchell of Satch Medical Consulting about how large diagnostics companies and startups alike are addressing the drive towards near-patient testing.

Integrating Ancillary Systems – A Bridge to Closed Cell Therapy Manufacturing Processes

Removing bottlenecks around media formulation, viral vector preparation and unique cell therapy reagents.

Fundraising and Venture Capital Trends with Caza Health

In this episode of Spilling the Tea, we talk with Peggy Robinson of Caza Health about fundraising during the pandemic, venture capital and grant trends post-COVID, keeping your vision and when to pivot as a startup.

Driving Down Costs of Autologous Cell Therapy Manufacturing

Panelists from Acepodia, Celyad and SOTIO discuss how cell therapies are impacted by the high cost of manufacturing and share their insights on ways to drive down costs.

How COVID is Accelerating Multi-Drug Resistant Infections with Selux Dx

In this episode of Spilling the Tea, we talk with Steve Lufkin of Selux Diagnostics about building a company culture during a pandemic, changes in the antibiotic susceptibility testing (AST) market and the current fundraising environment.

The Future of Complex POC Tests with MDC Associates

In the first episode of our new “Spilling the Tea” interview series, we talk with Joen Johansen of MDC Associates about government and private partnerships and the future of complex POC tests.

Diagnostic Product Development in a Post-Pandemic Era – New and Emerging Trends

Post COVID-19, accelerated development timelines, flexible manufacturing and the elevated role of the supply chain will be product development best practices.

Commercializing Disruptive Technologies in Advanced Therapies

From the back of the napkin to the bedside: Panelists from CUTISS, Humacyte and TreeFrog Therapeutics share their inspirational journeys commercializing disruptive technologies

The Case for Leveraging the Cloud in Point of Care Device Development

How smart, connected Point of Care devices improve efficiencies, reduce development costs and provide competitive advantage through differentiation.

Emergency Use Authorization: How IVD Developers Can Use the EUA to Address COVID-19

Watch our interview with Fran White of MDC Associates on using the EUA for COVID-19 testing to fast track approval, what’s required by the FDA and how to plan for an eventual 510(k).

Detecting Coronavirus at the Point of Care – In Search of Bold Breakthroughs

In the fight against the Coronavirus pandemic, rapid detection of the disease is key. Point of Care diagnostics can rise to the challenge by providing accelerated time to result at the point of need.

Got Approval… Now What? Meeting Cell Therapy Market Demand

Panelists from bluebird bio, DiscGenics and Proteus, LLC share their vision for commercial manufacturing of cell therapies.